drugset / Trial / NCT00136266

Adherence With Iron Sprinkles Among High-Risk Infants

NCT00136266

Phase 3 Completed 128 enrolled Centers for Disease Control and Prevention
RandomizedParallel-groupOpen-labelPrevention

Summary

Compared with iron drops, iron sprinkles supplied for 3 months to high-risk children beginning at age 5-7 months will increase adherence and reduce the rates of anemia and iron deficiency.

Timeline

Start
2005-03
Primary completion
2005-12
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferrous Sulfate Diagnostic / imaging agent